With over 1 million visitors to our blog and sites and thousands of visitors daily Sierra World Equity Review will be giving massive MULTIPLE DAY targeted audience exposure to our NEW PUBLISHER ALERT # 13, Optex Systems Holdings (OPXS), the share price is only going to explode upwards predicts Sierra World Equity Review.
Providing special focus to speculative potential mergers, acquisitions, buyouts, and joint ventures as well as BUY or SELL ratings along with 10 day short term PRICE TARGETS! With countless accurate calls, Sierra World Equity Review is lighting up the stock market with our accurate forecasts and predictions!!
Top Oil And Gas Stocks MHR,CHK, KOG
Best Gold Stocks ABX, NEM, ANV
Top Insurance Stocks MET, PRU, MFC
Hot ETF's EEM, EWJ, GDX
Best Marijuana Stocks LXRP, HEMP, ERBB
Tuesday, July 31, 2012
breaking piece...Sierra World Equity Review to Announce BUYOUT date Press Conference Announcement for ARNA
We called it correctly days in advance for both when when Belviq was approved by the FDA and also CORRECTLY that Qnexa (Qsymia) from Vivus would be approved by the FDA (just look at the links below for proof!!). Repeating, we are VERY ACCURATE in our predictions.
Riddle: if Arena, Pfizer and Eisai Deputy President Hajime Shimizu sat together what would they talk about.....
Monday, July 30, 2012
is Sierra going to appear on new Punch Reality TV show...she loves the nightlife...IC Places (ICPA) dancing tonight at ...
Sierra (Curveblack) boxer shorts
So tomorrow we are back on the trail, we believe that we know the date the buyout of Arena Pharmaceuticals will happen, I can't wait to tell everyone....just as soon as I can get the go ahead! Also Sierra World Equity Review ventures that Eisai and Pfizer have been also having discussions, in fact tomorrow Adam and I will be tracking down a key figure from Eisai here in NYC who we heard has been having meetings with Pfizer.....more about that tomorrow....oh yes, before I forget I will be deleting my Facebook account and moving everything onto my new website http://sierraworldequityreview.com/
That way I am able to control the content, had lots of fun doing the live discussions and look forward to the same when my site is up and running....right now it's still under construction as they say. Ok...that's it for now if you are in NY come on down and meet me at Le Royale tonight. Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report......be the first to read our new posts follow us on Twitter at https://twitter.com/#!/
Sierra (Curveblack) boxer shorts
Sunday, July 29, 2012
ps....something fun... Sierra is currently planning to invite a couple of her readers (longs only please), to accompany her for a week (all expenses paid) to watch her in action as she follows her passions around the world.....if you are interested please check back for more information on this as Sierra puts this together.
So moving forward looks like I'll be flying to NYC on Monday, Adam's boyfriend Johnny clued us in to the fact that a top Deputy at Eisai was seen the other day at Pfizer HQ in Manhattan....going to try catch him and get some answers! Also possibly have another ARNA long party In NYC...check back, I'll keep you posted. Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report......be the first to read our new posts follow us on Twitter at https://twitter.com/#!/
Arena Pharmaceuticals to be SUPERSTAR of the year- a must for LONGS to read - Sierra World Equity Review
Yikes, just when Sierra World Equity Review thought we had it nailed what did we stumble across? Swiss drug giant
!! Arena Pharmaceuticals "STOCK OF THE YEAR"-- a $100 Stock in the Making !!
Pfizer (PFE) suffered another setback today when an experimental drug, bapineuzumab which failed one of it's significant late stage trials to improve cognitive and life function, the primary goals of the trial. Working together with Johnson & Johnson (JNJ) the trial involved people who carry a variation of a gene called ApoE4 that makes them far more likely to develop Alzheimer's disease. This was a critical setback in a late stage trial for Pfizer. Sierra World Equity Review predicts that this will only strengthen Pfizer's ambitions to purchase Arena Pharmaceuticals (ARNA) and gain a slice of the huge obesity market with a drug, Belviq, that had already been approved by the FDA. Pfizer is fast losing revenue streams as patents expire on some of it's blockbuster drugs, failing in trials of their new pipeline drugs puts Pfizer in a desperate situation, they need a lifeline and Sierra believes they see that in Arena Pharmaceuticals. Needless to say a BUYOUT of Arena Pharmaceuticals will significantly enrich the current Arena shareholders. Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report .....please check back and be the first to read our new posts follow us on Twitter at https://twitter.com/#!/
Saturday, July 28, 2012
breaking...Why would Eisai Deputy President Hajime Shimizu be seen at Pfizer (PFE) HQ in NYC and what does it have to do with Arena Pharmaceuticals
It's all quite interesting, that's why I love to write about stocks, you never know what is going to happen especially in the biotech sector. So we will continue to follow this and see if it leads anywhere....looks like I'll be heading to NYC asap. This is just another piece in a puzzle that appears to be coming together....also on my agenda is another Arena longs party, maybe in the Big Apple, I had so much fun at the last one in Key West, thanks to those who watched us on the live web cam and to those that came down to party with me...check back I'll keep you all updated on my plans, got lots in store like my website (under construction as they say), where I plan to hold live Skype meetings so we all can chat about my current favorite stock ARNA, see upcoming live party events, see my recent smoking hot modelling pics from the beaches of South Africa, watch my live Great White Shark cage trip where I get in the water surrounded by Great Whites...plus much more...... I'm a very busy gal and I also want to take along a couple of my ARNA long readers for a week...see if you can keep up with me boys:) ......Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report......be the first to read our new posts follow us on Twitter at https://twitter.com/#!/
http://www.facebook.com/sierra.review send a friend request, I'll friend you then we can chat about ARNA or anything that's interesting to me....if you missed me tonight I'll be back on tomorrow around the same time..... in response to some of my readers asking for more photos of me, I also just added some of my recent "fun in the sun" modelling shoot pics from Cape Town, South Africa onto my Web page.
Friday, July 27, 2012
breaking....Why ARNA Volume is so low...those in the KNOW are keeping their shares---Sierra told you great things are coming!
Value of Arena Pharmaceuticals just went through the ROOF! Sierra World Equity Review ventures that pipeline drug APD811 will cruise to FDA approval....
Sierra World Equity Review is now predicting that one of Arena Pharmaceuticals pipeline drugs in Phase 1 clinical trials will cruise through the FDA approval process. Sierra World Equity Review also anticipates that work on APD811 will now go into high gear with Belviq under Arena's belt. The drug known now as APD811 is taken orally for the treatment of pulmonary arterial hypertension. Current medications for this on the market have to be taken continuously through intravenous, subcutaneous or inhaled delivery methods. So something that can be simply taken orally is a very attractive option. Sierra World Equity Review believes that while much of the news has centered around Belviq, Arena's newly FDA approved obesity drug other players in the industry also know that APD811 will likely get FDA approval and so companies like Pfizer see not just a Belviq revenue stream but also tremendous revenue potential for APD811. Sierra World Equity Review wonders just how long ARNA share price will stay this low before taking off like a rocket making ARNA shareholders some serious money!
From Arena Pharmaceuticals page here is info on APD81: "APD811, an orally available agonist of the prostacyclin receptor, is intended for the treatment of pulmonary arterial hypertension, or PAH. In December 2010, we initiated a Phase 1 clinical trial to evaluate the safety, tolerability and pharmacokinetics of single-ascending doses of APD811. We believe the results of this early stage clinical trial suggest APD811 has the potential for once-daily, oral dosing. We plan to initiate a multiple-dose, dose-titration, Phase 1 clinical trial of APD811.
Thursday, July 26, 2012
What does Pfizer know about APD811 Arena's pipeline drug that they want it MORE they want Belviq in Sierra's opinion ....both to be BLOCKBUSTERS believes Sierra World Equity Review
...more pictures of me to come when I publish my website http://sierraworldequityreview.com (under construction) coming soon...also will have info how I want to select two people who I'd like to take for a week on the road with me to see how fun my life is...I'm so excited and so lucky....big day tomorrow with Roche CEO....back to sleep!
Wednesday, July 25, 2012
breaking...it's 1:45am Key West time I stayed up to late...breakfast with Roche CEO in the morning at La Concha maybe..
Roche Chairman Franz Humer to give Sierra World Equity Review confirmation of European Partnership with Arena Pharmaceuticals? Sierra is on the last flight out to Key West in pursuit of Franz Humer
Due to MASSIVE requests Sierra gives in to her publisher and UPDATES her profile...see who Sierra really is!
ps....something fun... Sierra is currently planning to invite a couple of her readers (longs only please), to accompany her for a week (all expenses paid) to watch her in action as she follows her passions around the world.....if you are interested please check back for more information on this as Sierra puts this together. Follow us on Twitter at https://twitter.com/#!/
Tuesday, July 24, 2012
breaking....Roche to be European Partner for Arena Pharmaceuticals obesity drug Belviq ventures Sierra World Equity Review....here is why..
Another CORRECT call - KMA Global Solutions (KMAG) falls 2.22% --Sierra World Equity Review is SMOKING HOT!!
Sierra actually likes KMAG and we plan to be featuring the stock in some upcoming articles. Sierra has a message to the shareholders of KMAG, do not stress about today it was more of a slight technical correction and there is NOTHING WRONG with the stock.....there is some interesting and positive news coming for KMAG. Please check back as we are working on a current article that WILL make the shareholders be very happy they are in this stock! Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report......be the first to read our new posts follow us on Twitter at https://twitter.com/#!/